Transrectal Prostate Ultrasound TRUS and Uroflowmetry in Da Nang – Precision BPH Volume and IPP Assessment With Dr. Dang Phuoc Dat

1. Why Routine Abdominal Ultrasound Is Often Not Enough for Prostate Evaluation

Many expats and international retirees in Vietnam undergo general health check-ups that include a basic transabdominal pelvic ultrasound. However, because the prostate sits deep behind the pubic bone (pubic symphysis), abdominal ultrasound waves must pass through the abdominal wall and a full bladder at an oblique angle:

• Up to 25–35% Volume Error: Abdominal wall thickness, bowel gas, or an under-filled bladder frequently distort transabdominal measurements, either overestimating or underestimating true prostate size.
• Poor Visualization of Zonal Anatomy: Abdominal probes (3.5–5 MHz) cannot clearly distinguish the transition zone (where Benign Prostatic Hyperplasia – BPH grows) from the peripheral zone (where 75–80% of prostate cancers arise).
• High-Frequency Transrectal Ultrasound (TRUS – 7.5 to 10 MHz): By placing a slim, lubricated probe just millimeters from the posterior prostatic capsule, TRUS delivers crystal-clear visualization of the transition zone, seminal vesicles, ejaculatory ducts, prostatic calcifications, and exact Intravesical Prostatic Protrusion (IPP).

2. Understanding Intravesical Prostatic Protrusion (IPP): Why Small Prostates Can Cause Severe Blockage

One of the most important breakthroughs in modern urology (EAU 2026 Guidelines) is recognizing that prostate symptom severity does not depend on total prostate weight alone—it depends heavily on prostate architecture, specifically Intravesical Prostatic Protrusion (IPP):

• Grade I IPP (< 5 mm protrusion into the bladder base): Mild bladder neck elevation; high (>75–80%) response rate to oral Alpha-1A blocker monotherapy.
• Grade II IPP (5 to 10 mm protrusion): Moderate median lobe enlargement creating partial dynamic obstruction during detrusor contraction.
• Grade III IPP (> 10 mm protrusion): Severe “ball-valve” effect. When the bladder contracts to push urine out, hydrodynamic forces push the protruding median lobe tighter into the internal urethral orifice. Men with Grade III IPP have a high rate of medical therapy failure and a 6-fold higher risk of Acute Urinary Retention (AUR), even if their total prostate volume is only 35–45 mL.

3. Digital Uroflowmetry & Post-Void Residual (PVR): Measuring Real-Time Bladder Function

While TRUS reveals the anatomical structure of the prostate, Digital Uroflowmetry objectively measures how well your bladder and urethra function together during natural urination (valid when voided volume is 150–400 mL):

• Qmax > 15 mL/s (Bell-Shaped Curve): Normal, unobstructed urinary flow emptying completely within 20–30 seconds.
• Qmax 10 – 15 mL/s (Asymmetric / Prolonged Curve): Mild-to-moderate prostatic obstruction or early detrusor underactivity.
• Qmax < 10 mL/s (Compressive / Low-Amplitude Curve): High clinical probability (>90%) of significant Bladder Outlet Obstruction (BOO) requiring active medical or endoscopic intervention.
• Flat Plateau (Box-Shaped) Curve: Classic signature of a Urethral Stricture or rigid bladder neck contracture rather than simple BPH.

4. Clinical Stratification Table: Combining TRUS, IPP, Qmax, and PVR to Guide Treatment

5. Step-by-Step Patient Preparation for Your TRUS & Uroflowmetry Appointment in Da Nang

At Family Hospital Da Nang (Clinic Room 326), Dr. Dang Phuoc Dat performs the entire prostate diagnostic workup efficiently in one morning:

1. Step 1 – PSA Blood Draw First (If Required): If you need Total & Free PSA testing, venous blood is drawn before the Digital Rectal Exam (DRE) and TRUS so prostate manipulation does not falsely elevate serum PSA.
2. Step 2 – Arrive with a Comfortably Full Bladder for Uroflowmetry: Drink 400–500 mL of water 45–60 minutes before your visit so you feel a natural, comfortable urge to urinate (target voided volume: 150–400 mL). You simply void privately into our digital uroflowmeter sensor.
3. Step 3 – Immediate PVR & Gentle TRUS Examination: Right after voiding, we measure your Post-Void Residual volume, followed by a brief 5-minute Transrectal Ultrasound lying comfortably on your left side using sterile anesthetic gel.

6. Frequently Asked Questions (FAQ) About TRUS & Uroflowmetry in Da Nang

Q1: Is a Transrectal Prostate Ultrasound (TRUS) painful, and does it require anesthesia?

No anesthesia or sedation is needed. A diagnostic TRUS probe is thinner than an index finger, covered with a sterile sheath and generous numbing lubricant gel. Patients feel mild pressure for 3 to 5 minutes—similar to a standard Digital Rectal Exam—and can drive or return to normal activities immediately afterward.

Q2: Why did my uroflowmetry test have to be repeated when I voided less than 150 mL?

According to International Continence Society (ICS) and EAU standards, the bladder muscle (detrusor) requires at least 150 mL of stretch volume to generate a representative contraction. Voiding less than 150 mL can make a healthy bladder appear falsely weak, whereas over-holding beyond 500 mL can temporarily fatigue the muscle.

Q3: Can TRUS alone diagnose or rule out prostate cancer?

While TRUS accurately detects hypoechoic peripheral zone lesions and calculates exact PSA Density (PSAD = Total PSA divided by TRUS prostate volume; normal < 0.15 ng/mL/cc), ultrasound alone cannot rule out early microscopic prostate cancer. When PSA or DRE is suspicious, we combine TRUS PSAD with 3.0 Tesla Multiparametric Prostate MRI (mpMRI PI-RADS v2.1) for definitive risk stratification.

References (Vancouver Style)

1. Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, et al. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) 2026: Diagnostic Evaluation (Uroflowmetry, PVR, and Prostate Imaging). Arnhem: European Association of Urology Guidelines Office; 2026.
2. Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91(4):371-374.
3. Gammie A, Clarkson B, Constantinou C, Damaser M, Drinnan M, Geleijnse G, et al. International Continence Society guidelines on urodynamic equipment performance and uroflowmetry standardization. Neurourol Urodyn. 2014;33(4):370-379.
4. Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline 2023/2026 Update. J Urol. 2024;211(1):11-19.